Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.
Ontology highlight
ABSTRACT: In utero hematopoietic cell transplantation (IUHCT) has the potential to cure congenital hematologic disorders including sickle cell disease. However, the window of opportunity for IUHCT closes with the acquisition of T-cell immunity, beginning at approximately 14 weeks gestation, posing significant technical challenges and excluding from treatment fetuses evaluated after the first trimester. Here we report that regulatory T cells can promote alloengraftment and preserve allograft tolerance after the acquisition of T-cell immunity in a mouse model of late-gestation IUHCT. We show that allografts enriched with regulatory T cells harvested from either IUHCT-tolerant or naive mice engraft at 20 days post coitum (DPC) with equal frequency to unenriched allografts transplanted at 14 DPC. Long-t
SUBMITTER: Riley JS
PROVIDER: S-EPMC7094012 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA